Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-09-21

Clinical Trial Update: The Effects of Levosimendan on Haemodynamics in Patients Undergoing Elective Aortic Valve Replacement (AVR)Together With Coronary Artery Bypass Grafting (CABG) Surgery [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update investigates the effects of levosimendan on haemodynamics in patients undergoing elective aortic valve replacement with concu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levosimendan (levosimendan)

Snippet

Sponsor: Tampere University Hospital | Conditions: Heart Valve Disease | Phase 4 | Status: COMPLETED